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Abstract Although rare, inflammatory myofibroblastic tu-
mor is the most common primary lung mass in children. We
report the case of an 11-year-old boy investigated for persis-
tent cough and dyspnea with complete left lung atelectasis
mimicking pneumonia. CT and MRI showed an endobron-
chial mass of the left main bronchus. The boy underwent
endoscopic resection of the tumor and histology was in favor
of an inflammatory myofibroblastic tumor of the lung. This
diagnosis should be suspected in children with recurrent
pneumonia. The prognosis is good after complete resection.
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Introduction
Inflammatory myofibroblastic tumor (IMT) of the lung is a
rare benign tumor first described by Brunn in 1939, as cited by
Jeba et al. [1]. It belongs to the group of soft-tissue tumors and
is also called inflammatory pseudotumor, fibrous histiocy-
toma, plasma cell granuloma, plasmocytoma, solitary mast
cell tumor, pseudoneoplastic pneumonia or fibroxanthoma.
IMT can involve any anatomical location, but the lung is the
most commonly affected site in children as well as in adults. The
other anatomical locations are head and neck, mesentery, liver
and bladder. In children, IMT is the most common primary lung
mass that can behave like malignant tumors. Clinical presenta-
tion and radiologic findings are variable and not specific. Diag-
nostic confirmation is based on histological examination.
Case report
An 11-year-old otherwise healthy boy had a 2-month history
of dyspnea and coughs and was treated for asthma with no
clinical improvement. One month after the onset of respira-
tory symptoms, he developed fever and the cough became
persistent. Chest radiograph showed left lower lobe atelec-
tasis. The diagnosis of pneumonia was established and anti-
biotherapy prescribed. One month later, he was referred to
our emergency department because of unsatisfactory clinical
course with complete left lung radiologic atelectasis (Fig. 1).
White blood cell count, blood chemistry and CRP level
were unremarkable. Tuberculin skin test was negative.
Chest US showed pulmonary consolidation without signif-
icant pleural effusion. Chest CTwas performed on a 16-slice
machine (GE LightSpeed, Waukesha, WI, USA) after intra-
venous 2 ml/kg injection of a 300 mgI/ml contrast medium
(CTDI of 6.44 mGy). Besides total atelectasis of the left
lung with mediastinal shift to the left and compensatory
overinflation of the right lung, CT showed a well-delineated
homogeneous mass of 1.8×1.2×1.7 cm in the left main
bronchus (Fig. 2). This lesion completely obstructed the
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main bronchus and was not enhanced by contrast material.
Chest MRI was performed on a 1.5-T (Magnetom Avanto,
Siemens, Erlangen, Germany) and imaging protocol
included Balanced Steady-State Free Precession (bSSFP),
coronal T1-weighted turbo spin-echo sequences (TR/TE
641/22 ms), axial and coronal T2-weighted turbo spin echo
(TR/TE 1,000/80 ms) and fat-suppressed T1-weighted spin-
echo sequences after intravenous administration of gadobutro-
lum (Gadovist, Bayer, Zurich, Switzerland) at a dose of
0.1 mmol/kg body weight. MRI confirmed the presence of a
homogeneous mass in the left main bronchus with high signal
intensity on T2- and T1-weighted images with no significant
contrast enhancement (Fig. 3). Whole-body MRI was also
performed and the protocol included 3-D inversion recovery
(inversion time0160 ms) T2-weighted turbo spin-echo
(SPACE, TR/TE 2,000/151 ms, isotropic voxel dimensions,
1.4 mm), coronal T1-weighted spin-echo sequences (TR/TE
550/11) and diffusion. No other lesion was found. On [F-18]-
fluoro-2-deoxyglucose (FDG) PET/CT (Biograph 16; Siemens,
Erlangen, Germany), this mass showed increased metabolism
(SUVmax 21.8) (Fig. 4). No other hypermetabolic lesions were
found on PET/CT. Lung volumes were markedly decreased
with a restrictive syndrome (total lung capacity 55% of pre-
dicted) on spirometric studies. Bronchoscopy visualized the
endobronchial tumor, which was obstructing incompletely the
distal end of the left main bronchus (Fig. 5). The polypoid shape
Fig. 1 The chest radiograph shows complete left lung atelectasis with
compensatory overinflation of the right lung
Fig. 2 Contrast-enhanced and reformatted coronal (a) and axial (b)
CT images show an obstructive homogeneous, well-circumscribed and
non-enhanced mass in the left main bronchus (arrows)
Fig. 3 Axial T2-weighted MR image shows a well-delineated mass
(arrow) with high signal intensity in the left main bronchus and
atelectasis of the left lung
Fig. 4 Fused coronal PET/CT image demonstrates intense 18F-FDG
uptake in the pulmonary mass (arrow)
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of the tumor allowed total endoscopic resection with a diather-
mic snare combined with argon plasma coagulation and no
complications. Histological analysis revealed a mesenchymal
tumor more commonly called inflammatory myofibroblastic
tumor. Cytogenetic analysis confirmed this diagnosis with pos-
itive characteristic rearrangement at 2p23.9 of the gene coding
for the anaplastic lymphoma kinase receptor tyrosine kinase
(found in 50% of IMT cases). Chest radiographs after resection
showed complete resolution of the atelectasis. Spirometry
showed normal total lung capacity, and repeated bronchoscopies
at 1-month and 3-month follow-ups were normal.
Discussion
Most of the causes of atelectasis in childhood are related to
airway obstruction. Intrabronchial obstruction may be exog-
enous due to foreign body, or to mucous plugs. Endobron-
chial tumors are a rare cause of atelectasis.
IMT is a rare lesion; it belongs to the group of soft-tissue
tumors and has also been called inflammatory pseudotumor,
fibrous histiocytoma, plasma cell granuloma, plasmocytoma,
solitary mast cell tumor, pseudoneoplastic pneumonia, and
fibroxanthoma. This is probably due to its predominant cellular
component. It can involve any anatomical location; however,
the lung is the most commonly affected site [2]. Other frequent
locations include the bladder, mesentery, omentum, retroperito-
neum, pelvis, gastrointestinal tract, liver, spleen, kidney and
pancreas. Some tumors can be multifocal and involve several
organs. The true incidence of IMT of the lung is difficult to
establish because of various nomenclatures used. However, it is
relatively rare among all primary lung neoplasms, accounting
for only 0.04%–0.7% of them [3]. According to many series,
IMT is the most common primary childhood lung tumor, with
an incidence ranging from 12% to 57% [2]. There is a near equal
male/female occurrence [2, 4].
Pathophysiologically, an unregulated proliferation of in-
flammatory cells seems to be present [3]. The cause of this
inflammatory response remains unknown. It has been hypoth-
esized that an initial infection leads to IMT, and about 30% of
patients have had a history of respiratory infection. In a case
report Fiocchi et al. [5] described a direct progression from
infectious disease to an IMT. Inflammatory lesions are thought
to occur locally as a result of excessive response to tissue
damage [6]. Others believe it to be a real neoplasm induced by
genic reorganizations on the chromosome 23 [7].
Most frequent symptoms are cough, hemoptysis, chest
pain, dyspnea and fever. It may also be asymptomatic [7].
Radiologic findings are variable and unspecific. The most
common radiologic presentation is a solitary peripheral well-
circumscribed lung mass, with variable size between 1.5 cm
and 14 cm according to a series of 28 cases reported by Kim et
al. [8]. The endobronchial polypoid forms arising in the tra-
chea or the bronchus are the rarest but have also been reported,
as in our case. They can show atelectasis and obstructive
pneumonia and can spread into the mediastinum.
Contrast-enhanced CT or MRI is necessary to view the
endobronchial mass that is not visible on the chest radiograph.
CTand MRI allow a better characterization and delineation of
the tumor. Contrast-enhanced CT shows a homogeneous or
heterogeneous attenuated mass. Intralesional calcifications are
possible but rare, and are shown more frequently in pediatric
cases [4, 7]. IMTs are also known to rarely form a cavity. In
such cases, MRI shows intermediate signal intensity on T1-
weighted images and high signal intensity on T2-weighted
images. Absent or delayed enhancement with contrast injec-
tion on CT or MRI is described in the literature. Takayama et
al. [4] reported two cases of IMT that were intra-pulmonary
well circumscribed masses. Dynamic contrast enhancement
CT in both cases showed delayed enhancement. They specu-
late that the delayed enhancement could be attributed to
abundant fibrous tissues such as myofibroblasts [4]. High
fixation of 18F-FDG of IMT on PET has been described [7]
and may be used for assessment of multifocal forms.
Concerning transbronchial biopsy and transthoracic needle
biopsy, Cerfolio et al. [2] believe that they often lead to confusion
between IMTand fibrohistiocytic neoplasms, nodular sclerosing
Hodgkin lymphoma, primary lung cancer and mediastinal fibro-
sis. Indeed, histological findings of a fragment cannot exclude a
neoplasm with surrounding inflammation. Complete resection
for both diagnosis and treatment is mandatory.
While inflammatory myofibroblastic tumor is a rare endo-
bronchial tumor, it should be known as a possible cause of
atelectasis in children and distinguished from a malignancy.
The treatment is surgical, and a favorable prognosis relies on
complete resection.
Fig. 5 Endoscopic view of the left main bronchus shows an obstruc-
tive endobronchial mass
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